Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
As per available reports about 6 relevant journals, 436 Scientific conference proceedings and 108 National symposiums are presently dedicated exclusively to Active surveillance and and about 157 Open Access Articles are being published on Active surveillance.
Active surveillance is a way of monitoring slow-growing prostate cancer, rather than treating it straight away. The aim is to avoid unnecessary treatment, or delay treatment and the possible side effects.Today, the interdisciplinary care of prostate cancer has become a reality, and urologists along with radiation, surgical, and medical oncologists are all involved in the management of these patients. In order to provide optimal care, it is essential that all members of the treatment team stay up-to-date on current trends and emerging data, not just in their own area, but also in the related specialties such as Prostatitis Treatment & Management, Benign Prostatic Hyperplasia, Prostate Cancer: Clinical Urology, Histology of prostate cancer and Living and Managing Prostate Cancer
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance
Active Surveillance Conference provides the scope for opportunities to learn progressed by international scientists and academicians.Active surveillance is a treatment plan which involves watching a patient’s condition closely without giving any medicine or treatment unless his/her condition is getting worse.Active surveillance is practiced to avoid or delay the need of treatments such as radiation therapy and surgery , because of their side effects. During active surveillance some tests are done regularly.It is further used in treating different types of cancers like urethral cancer and prostate cancer .Active surveillance requires more time and is not recommended during emergencies. In case of small tumours in prostate and cancer appears to be slow growing active surveillance is recommended . The advantage of active surveillance for men with localized and early-stage prostate cancer is that they can avoid the side effects of radiation therapy and surgery including urinary incontinence, rectal bleeding, and erectile dysfunction.Active surveillance is not recommended for everyone with localised prostate cancer , because sometimes the cancer may become more aggressive.
Market Analysis
Active surveillance has emerged as an approach to avoid "overtreatment" of prostate cancer. In many cases, it can avoid surgery or radiation therapy that would entail a risk of complications and side effects without actually benefiting the patient. 71 percent of the physicians responded that their patients were not interested in active surveillance," the researchers write. The rate was over 80 percent for radiation oncologists, compared to 60 percent for urologists.
International symposium and workshops
European Cancer Congress 2015 , Sep 25-29 ,2015 , Vienna , Austria.
AACR .Annual Meeting 2015 , April 18-22, 2015 , Philadelphia, US.
European Lung Cancer Conference 2015 , April 15-18 , Geneva , Switzerland.
List of Best International Conferences
Pancreatic and Colorectal Cancer Conference
March 29-30, 2016 Atlanta, USA.
4th Blood Malignancies Conference
April 18-20, 2016 Dubai, UAE.
Gynecologic Oncology Conference
May 19-21, 2016 San Antonio, USA.
2nd Antimicrobial Agents and Chemotherapy Conference
June 6-7, 2016 Dallas, USA.
Cancer Diagnostics Conference
June 13-15, 2016 Rome, Italy.
10 Global Oncologists Conference
July 11-13, 2016 Cologne, Germany.
11th Oncology and Oncologists Conference
July 11-13, 2016 Kuala Lumpur, Malaysia.
Melanoma and Carcinoma Conference
July 14-15, 2016 Brisbane, Australia.
Neuro Onclogy Conference
July 21-23, 2016 Brisbane, Australia.
Thyroid Cancer Conference
Aug 1-3, 2016 Toronto, Canada.
Oral, Mouth and Throat Cancer Conference
Aug 18-20, 2016 Portland, Oregon.
Molecular & Cancer Biomarkers Conference
Sept 15-17, 2016 Berlin, Germany.
Cervical Cancer Conference
Sept 22-23, 2016 Vienna, Austria.
Radiation Oncology Conference
Sep 26-28, 2016 Valencia, Spain.
12th Cancer Therapy Conference
Sept 26-28, 2016 London, UK.
13th Oncologists and Cancer Therapy Conference
Oct 17-19, 2016 Dubai, UAE.
Mesothelioma Conference
Nov 3-4, 2016 Valencia, Spain.
Leukemia and Bonemarrow Tranplantation Conference
Nov 10-12, 2016 Istanbul, Turkey.
14th Cancer Therapy Conference
Dec 8-10, 2016 Baltimore, USA.
Relevant Society and Associations
American Cancer Society.
Cancer Research UK.
British Association of Urological Surgeons (BAUS).
National Cancer Institute.
Cancer society of New Zealand.
American society of clinical oncology.
Cancer Research foundation.
Cancer Research Institute.
Urological Association of Asia and Iranian.
Canadian Cancer Society.
List of Companies
Roche
Amgen.
Novartis.
Celgene.
Johnson & Johnson.
Lilly.
AstraZeneca.
Merck & Co.
Bristol-Myers Squibb.
Takeda.
This page will be updated regularly.
This page was last updated on November 5, 2024
